116 results
Page 2 of 6
424B5
9y2tcnk
28 May 21
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
53pdfyg yk
6 May 21
Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results
4:40pm
424B3
xltay 37h
15 Apr 21
Prospectus supplement
4:31pm
8-K
EX-99.1
3yi9alz9dc75
11 Mar 21
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2020 Financial Results
4:01pm
8-K
EX-99.1
o4dj 6aze5sr
28 Jan 21
Oncternal Therapeutics Announces the Appointment of Dr. Rosemary Mazanet to the Board of Directors
4:01pm
8-K
EX-99.1
cbiw7yvl
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
8-K
EX-99.2
8z38ewelpz nlgfe
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
424B5
j5rl0m05qs21
10 Dec 20
Prospectus supplement for primary offering
5:02pm
FWP
543i 7ka6jcwtk
10 Dec 20
Free writing prospectus
6:11am
FWP
2w0u8i 7ia
10 Dec 20
Free writing prospectus
12:00am
424B5
rpvj9xh 6j
10 Dec 20
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
sapi kf2l5scwi1
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
8-K
EX-99.2
1qx 15po6u
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
424B5
is9z hgvlr
19 Nov 20
Prospectus supplement for primary offering
12:00am